<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03906188</url>
  </required_header>
  <id_info>
    <org_study_id>IR 3/2018</org_study_id>
    <nct_id>NCT03906188</nct_id>
  </id_info>
  <brief_title>Serious Game for Fibromyalgia Patients</brief_title>
  <official_title>Development and Validation of a Serious Game for Fibromyalgia Patients: Pre-experimental Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Burgos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Burgos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim: To check the applicability of LitEmotion© in people with Fibromyalgia.

      Design: randomized clinical trial, with pre, post and follow-up evaluation. Researchers and
      outcome evaluator blinded.

      Method: The experimental group will play during three weeks to LitEmotion© videogame. The
      control group will not play.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a longitudinal-transversal research work with two groups. Findings will us
      prove the correlation between a right management of emotions and the perception of pain,
      daily life activities and quality of sleeping.

      Sample will be selected by following strict rules; people with no requirements will be
      dismissed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 30, 2019</start_date>
  <completion_date type="Actual">June 15, 2019</completion_date>
  <primary_completion_date type="Actual">May 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health Assessment Questionnaire (HAQ)</measure>
    <time_frame>Change from Baseline Independence Activities of the daily living up to 3 weeks</time_frame>
    <description>The HAQ evaluates the performance in the activities of daily living.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>Change from Baseline Independence Activities of the daily living up to 3 weeks</time_frame>
    <description>The PSQI is an unreported measure which evaluate the quality of sleep.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fibromyalgia Impact Questionnaire (FIQ)</measure>
    <time_frame>Change from Baseline Independence Activities of the daily living up to 3 weeks</time_frame>
    <description>The FIQ evaluates the quality of life in people with fibromyalgia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spanish Pain Questionnaire (SPQ).</measure>
    <time_frame>Change from Baseline Independence Activities of the daily living up to 3 weeks</time_frame>
    <description>The SPQ evaluates the kind of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogic scale (VAS)</measure>
    <time_frame>Change from Baseline Independence Activities of the daily living up to 3 weeks</time_frame>
    <description>The VAS evaluates the level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The spanish suggestibility inventory</measure>
    <time_frame>Pre-assessment</time_frame>
    <description>This inventory evaluates the level of suggestibility.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>LitEmotion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will play to LitEmotion video game.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will no do receive any intervention with the video game</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LitEmotion</intervention_name>
    <description>LitEmotion is a serious video game programmed for helping managing emotions. The experimental group will play during 3 weeks while the control group will not play. The sample will play during 21 days, one session daily, around 45 minutes. After the 21 sessions the group will stop playing during 3 weeks. Therefore, the scales are done three times. In the very beginning (before playing), 21 days after playing, and, finally, 21 days no playing.</description>
    <arm_group_label>LitEmotion group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fibromyalgia diagnosed

          -  Referred pain during the last month

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidad de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>09003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Carmona, L. G., L.;Ballina, J.; Laffon, A. (2001). Proyecto EPISER 2000: prevalencia de las enfermedades reumáticas en la población española. Metodología, resultados del reclutamiento y características de la población. Revista Española de Reumatología, 28(1), 18-25.</citation>
  </reference>
  <reference>
    <citation>Esteve-Vives J, Rivera J, A Vallejo M; Grupo ICAF. [Assessment of functional capacity in fibromyalgia. Comparative analysis of construct validity of three functional scales]. Reumatol Clin. 2010 May-Jun;6(3):141-4. doi: 10.1016/j.reuma.2009.10.008. Epub 2010 Jan 27. Spanish.</citation>
    <PMID>21794700</PMID>
  </reference>
  <reference>
    <citation>Leavitt F, Katz RS, Golden HE, Glickman PB, Layfer LF. Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum. 1986 Jun;29(6):775-81.</citation>
    <PMID>3487324</PMID>
  </reference>
  <reference>
    <citation>Rivera J, González T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004 Sep-Oct;22(5):554-60.</citation>
    <PMID>15485007</PMID>
  </reference>
  <reference>
    <citation>Rivera J, Alegre C, Ballina FJ, Carbonell J, Carmona L, Castel B, Collado A, Esteve JJ, Martínez FG, Tornero J, Vallejo MA, Vidal J. [Not Available]. Reumatol Clin. 2006 Mar;2 Suppl 1:S55-66. doi: 10.1016/S1699-258X(06)73084-4. Epub 2008 Dec 10. Spanish.</citation>
    <PMID>21794365</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>June 27, 2019</last_update_submitted>
  <last_update_submitted_qc>June 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Burgos</investigator_affiliation>
    <investigator_full_name>ANA MARIA LARA PALMA</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>serious game</keyword>
  <keyword>videogame</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

